Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-18T10:22:37.082Z Has data issue: false hasContentIssue false
  • English
  • Français

Basic science: (SEPTEMBER 2007)

Published online by Cambridge University Press:  01 December 2007

R Sutherland
R Sutherland
Affiliation:
Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Journals Watch
Information
Breast Cancer Online , Volume 10 , Issue 12 , December 2007 , e24
Copyright
Copyright © Cambridge University Press 2007

References

1.Abba, MC, Sun, H, Hawkins, KA, Drake, JA, Hu, Y, Nunez, MI, Gaddis, S, Shi, T, Horvath, S, Sahin, A, Aldaz, CM. Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status. Mol Cancer Res 2007; 5: 881–890.CrossRefGoogle ScholarPubMed
2. Alarmo EL, Korhonen T, Kuukasjaervi T, Huhtala H, Holli K, Kallioniemi A. Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas. Ann Oncol 2007; 10.1093/annonc/mdm453.CrossRefGoogle Scholar
3.Andarawewa, KL, Erickson, AC, Chou, WS, Costes, SV, Gascard, P, Mott, JD, Bissell, MJ, Barcellos-Hoff, MH. Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor β-induced epithelial to mesenchymal transition. Cancer Res 2007; 67: 8662–8670.CrossRefGoogle ScholarPubMed
4.Balasubramanian, SP, Cox, A, Cross, SS, Higham, SE, Brown, NJ, Reed, MW. Influence of VEGF–A gene variation and protein levels in breast cancer susceptibility and severity. Int J Cancer 2007; 121: 1009–1016.CrossRefGoogle Scholar
5.Bromberg, KD, Kluger, HM, Delaunay, A, Abbas, S, DiVito, KA, Krajewski, S, Ronai, Z. Increased expression of the E3 ubiquitin ligase RNF5 is associated with decreased survival in breast cancer. Cancer Res 2007; 67: 8172–8179.CrossRefGoogle ScholarPubMed
6.Buijs, JT, Henriquez, NV, Van Overveld, PGM, Van der Horst, G, Que, I, Schwaninger, R, Rentsch, C, Ten Dijke, P, Cleton-Jansen, AM, Driouch, K, Lidereau, R, Bachelier, R, Vukicevic, S, Clezardin, P, Papapoulos, SE, Cecchini, MG, Lowik, C, Van der Pluijm, G. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. Cancer Res 2007; 67: 8742–8751.CrossRefGoogle ScholarPubMed
7.Cao, Y, Luo, J, Karin, M. IκB kinase α kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells. Proc Natl Acad Sci USA 2007; 104: 15852–15857.CrossRefGoogle ScholarPubMed
8.Chen, D, Reierstad, S, Lin, Z, Lu, M, Brooks, C, Li, N, Innes, J, Bulun, SE. Prostaglandin E-2 induces breast cancer-related aromatase promoters via activation of p38 and c-jun NH2-Terminal kinase in adipose fibroblasts. Cancer Res 2007; 67: 8914–8922.CrossRefGoogle Scholar
9.Christov, K, Grubbs, CJ, Shilkaitis, A, Juliana, MM, Lubet, RA. Short-term modulation of cell proliferation and apoptosis and preventive/Therapeutic efficacy of various agents in a mammary cancer model. Clin Cancer Res 2007; 13: 5488–5496.CrossRefGoogle Scholar
10.Dairkee, SH, Nicolau, M, Sayeed, A, Champion, S, Ji, Y, Moore, DH, Yong, B, Meng, Z, Jeffrey, SS. Oxidative stress pathways highlighted in tumor cell immortalization: association with breast cancer outcome. Oncogene 2007; 26: 6269–6279.CrossRefGoogle ScholarPubMed
11.Deeb, KK, Michalowska, AM, Yoon, CY, Krummey, SM, Hoenerhoff, MJ, Kavanaugh, C, Li, MC, Demayo, FJ, Linnoila, I, Deng, CX, Lee, E, Medina, D, Shih, JH, Green, JE. Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis. Cancer Res 2007; 67: 8065–8080.CrossRefGoogle ScholarPubMed
12.Dupont, VN, Gentien, D, Oberkampf, M, De Rycke, Y, Blin, N. A gene expression signature associated with metastatic cells in effusions of breast carcinoma patients. Int J Cancer 2007; 121: 1036–1046.CrossRefGoogle ScholarPubMed
13.Fernando, R, Foster, JS, Bible, A, Strom, A, Pestell, RG, Rao, M, Saxton, A, Baek, SJ, Yamaguchi, K, Donnell, R, Cekanova, M, Wimalasena, J. Breast cancer cell proliferation is inhibited by BAD: Regulation of CYCLIN D1. J Biol Chem 2007; 282: 28864–28873.CrossRefGoogle ScholarPubMed
14.Gonzalez, ME, Peterson, EA, Privette, LM, Loffreda-Wren, JL, Kalikin, LM, Petty, EM. High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes. Cancer Res 2007; 67: 8554–8564.CrossRefGoogle ScholarPubMed
15.Green, KA, Carroll, JS. Opinion: Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state. Nat Rev Cancer 2007; 7: 713–722.CrossRefGoogle Scholar
16.Gutzman, JH, Rugowski, DE, Nikolai, SE, Schuler, LA. Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin-initiated signals in tumorigenesis dependent on cell context. Oncogene 2007; 26: 6341–6348.CrossRefGoogle ScholarPubMed
17.Hatsell, S, Frost, AR. Hedgehog signaling in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 2007; 12: 163–173.CrossRefGoogle ScholarPubMed
18.Hitosugi, T, Sato, M, Sasaki, K, Urnezawa, Y. Lipid raft-specific knockdown of src family kinase activity inhibits cell adhesion and cell cycle progression of breast cancer cells. Cancer Res 2007; 67: 8139–8148.CrossRefGoogle ScholarPubMed
19.Kerlikowske, K, Miglioretti, DL, Buist, DSM, Walker, R, Carney, PA. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst 2007; 99: 1335–1339.CrossRefGoogle Scholar
20. Knowlden J, Jones H, Barrow D, Gee J, Nicholson R, Hutcheson I. Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib (‘Iressa’) response and resistance. Breast Cancer Res Treat 2007; 10.1007/s10549-007-9763-9.CrossRefGoogle Scholar
21. Lagadec C, Adriaenssens E, Toillon RA, Chopin V, Romon R, Van Coppenolle F, Hondermarck H, Le Bourhis X. Tamoxifen and TRAIL synergistically induce apoptosis in breast cancer cells. Oncogene 2007; 10.1038/sj.onc.1210749.CrossRefGoogle Scholar
22.Liu, JC, Deng, T, Lehal, RS, Kim, J, Zacksenhaus, E. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors. Cancer Res 2007; 67: 8671–8681.CrossRefGoogle ScholarPubMed
23.Ma, L, Teruya-Feldstein, J, Weinberg, RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682–688.CrossRefGoogle ScholarPubMed
24.McBryan, J, Howlin, J, Kenny, PA, Shioda, T, Martin, F. ER α-CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis. Oncogene 2007; 26: 6406–6419.CrossRefGoogle Scholar
25.McGowan, EM, Russell, AJ, Boonyaratanakornkit, V, Saunders, DN, Lehrbach, GM, Sergio, CM, Musgrove, EA, Edwards, DP, Sutherland, RL. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-Isoform of progesterone receptor. Cancer Res 2007; 67: 8942–8951.CrossRefGoogle ScholarPubMed
26.Melana, SM, Nepomnaschy, I, Sakalian, M, Abbott, A, Hasa, J, Holland, JF, Pogo, BGT. Characterization of viral particles isolated from primary cultures of human breast cancer cells. Cancer Res 2007; 67: 8960–8965.CrossRefGoogle ScholarPubMed
27. Milliken EL, Lozada KL, Johnson E, Landis MD, Seachrist DD, Whitten I, Sutton ALM, Abdul-Karim FW, Keri RA. Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer. Oncogene 2007; 10.1038/sj.onc.1210815.CrossRefGoogle Scholar
28.O’Neill, CF, Urs, S, Cinelli, C, Lincoln, A, Nadeau, RJ, Leon, R, Toher, J, Mouta-Bellum, C, Friesel, RE, Liaw, L. Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth. Am J Pathol 2007; 171: 1023–1036.CrossRefGoogle ScholarPubMed
29.Stang, MT, Armstrong, MJ, Watson, GA, Sung, KY, Liu, Y, Ren, B, Yim, JH. Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells. Oncogene 2007; 26: 6420–6430.CrossRefGoogle ScholarPubMed
30.Stender, JD, Frasor, J, Komm, B, Chang, KCN, Kraus, WL, Katzenellenbogen, BS. Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation. Mol Endocrinol 2007; 21: 2112–2123.CrossRefGoogle ScholarPubMed
31.Stingl, J, Caldas, C. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer 2007; 7: 791–799.CrossRefGoogle ScholarPubMed
32.Tang, B, Yoo, N, Vu, M, Mamura, M, Nam, JS, Ooshima, A, Du, Z, Desprez, PY, Anver, MR, Michalowska, AM, Shih, J, Parks, WT, Wakefield, LM. Transforming growth factor-β can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model. Cancer Res 2007; 67: 8643–8652.CrossRefGoogle ScholarPubMed
33.Ursini-Siegel, J, Rajput, AB, Lu, HL, Sanguin-Gendreau, V, Zuo, DM, Papavasiliou, V, Lavoie, C, Turpin, J, Cianflone, K, Huntsman, DG, Muller, WJ. Elevated expression of DecR1 impairs ErbB2/Neu-Induced mammary tumor development. Mol Cell Biol 2007; 27: 6361–6371.CrossRefGoogle ScholarPubMed
34.Vachon, CM, Sellers, TA, Carlson, EE, Cunningham, JM, Hilker, CA, Smalley, RL, Schaid, DJ, Kelemen, LE, Couch, FJ, Pankratz, VS. Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer. Cancer Res 2007; 67: 8412–8418.CrossRefGoogle Scholar
35.Vaidya, KS, Welch, DR. Metastasis suppressors and their roles in breast carcinoma. J Mammary Gland Biol Neoplasia 2007; 12: 175–190.CrossRefGoogle ScholarPubMed
36.Vargo-Gogola, T, Rosen, JM. Modelling breast cancer: one size does not fit all. Nat Rev Cancer 2007; 7: 659–672.CrossRefGoogle Scholar
37.Voorzanger-Rousselot, N, Goehrig, D, Journe, F, Doriath, V, Body, JJ, Clezardin, P, Garnero, P. Increased Dickkopf-1 expression in breast cancer bone metastases. Br J Cancer 2007; 97: 964–970.CrossRefGoogle ScholarPubMed
38.Wang, N, Lin, KK, Lu, Z, Lam, KS, Newton, R, Xu, X, Yu, Z, Gill, GN, Andersen, B. The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells. Oncogene 2007; 26: 6431–6441.CrossRefGoogle ScholarPubMed
39.Wedren, S, Magnusson, C, Humphreys, K, Melhus, H, Kindmark, A, Stiger, F, Branting, M, Persson, I, Baron, J, Weiderpass, E. Associations between androgen and vitamin D receptor microsatellites and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 1775–1783.CrossRefGoogle ScholarPubMed
40.Woodfield, GW, Horan, AD, Chen, Y, Weigel, RJ. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling. Cancer Res 2007; 67: 8439–8443.CrossRefGoogle ScholarPubMed
41.Yuan, YH, Qin, L, Liu, D, Wu, RC, Mussi, P, Zhou, SL, Zhou, SY, Xu, J. Genetic screening reveals an essential role of p27kip1 in restriction of breast cancer progression. Cancer Res 2007; 67: 8032–8042.CrossRefGoogle ScholarPubMed